HMMR and breast carcinoma: The investigation unveiled an upregulation and overexpression of HMMR across almost all tumor samples, including various breast cancer stages, such as individual cancer stages, histological subtypes, breast cancer sub-classes, TNBC subtypes, and those based on patient age (Figure 4).